News ESMO26: Moderna, MSD reveal cancer jab data early after leak Moderna and MSD shared the results for their melanoma cancer vaccine trial, ahead of a presentation at ESMO tomorrow, after a data breach.
News AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.
News Roche posts solid results ahead of looming patent cliff Roche's Q3 pharma sales rose a healthy 7%, although the first signs of weakness for blockbuster product Xolair are a warning of tougher times ahead.
News Clinical trial setup times fall sharply in UK Reforms to the regulatory framework for clinical research in the UK are starting to deliver, with delivery times down 35%, according to new data.
News UK trial 'could halve time to test Alzheimer's drugs' A pioneering UK study, AD-SMART, will test multiple repurposed and new drugs in parallel to try to slash the time it takes to gauge their efficacy.
News Despite US policy changes, drug prices stay stubbornly high US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.